90-C-95 Phase I study of intrathecal mafosfamide (rev: 8/92)

Principal Investigator: Dr. Frank Balis

92-C-0137: A Trial of Carboxypeptidase-G2 (CPDG2) for the Management of Patients with Intrathecal Methotrexate Overdose

Principal Investigator: Dr. Brigitte Widemann

01-C-0123 A Phase II Study of Intrathecal Topotecan (NSC #609699) in Patients with Refractory Meningeal Malgnancies

Principal Investigator: Dr. Frank Balis

Also see Pharmacology and Experimental Therapeutics Section

Last Updated: April 15, 2003

NCI Home Page|| NIH Home Page

© 2002-2003, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute